30 Oct 2023
RIT Biotech, the manufacturing arm of ZERO Biotech, is delighted to be a part of the highly anticipated 15th Urology Symposium as a sponsor and exhibitor. The symposium, which is an annual event organized by the Division of Urology, Department of Surgery, The Chinese University of Hong Kong(CUHK), was held on 28th, October, at Kerry Hotel in Hong Kong.
The Urology Symposium brings together renowned urologists and healthcare professionals worldwide for ideas and knowledge exchange.
As a dedicated biotechnology company, RIT Biotech is committed to support the advancement of the urology field by providing high quality radiopharmaceuticals, as well as by the research and development of innovative radiopharmaceuticals together with ZERO Biotech . During the symposium, RIT Biotech showcased its latest development of Lu177 PSMA treatment to leading urologists and healthcare professionals.
The Faculty of Medicine, CUHK, is one of the two tertiary medical education institutes in Hong Kong. Besides providing high quality clinical training, it also initiates and manages cutting edge medical research over the past few decades. The 15th Urology Symposium therefore offers an ideal platform for RIT Biotech and ZERO Biotech to interact with clinicians and researchers at the Faculty of Medicine, CUHK, to exchange ideas about clinical studies to improve the treatment protocol to enhance the treatment efficacy and experience.
Together with ZERO Biotech, RIT Biotech is dedicated to driving innovation in the field of uro-oncology. With a focus on research, development, and commercialization of advanced solutions, RIT Biotech strives to improve clinical outcomes and enhance the quality of urological care.
